MAIA: MAIA Biotechnology, Inc. Stock

by  •  • Comments Off on MAIA: MAIA Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 55.16
Enterprise Value ($M) 48.01
Book Value ($M) 0.48
Book Value / Share 0.02
Price / Book 115.51
NCAV ($M) 0.47
NCAV / Share 0.02
Price / NCAV 116.19

Profitability (mra)
Return on Invested Capital (ROIC) -41.41
Return on Assets (ROA) -2.18
Return on Equity (ROE) -3.89

Liquidity (mrq)
Quick Ratio 1.53
Current Ratio 1.53

Balance Sheet (mrq) ($M)
Current Assets 7.56
Assets 7.57
Liabilities 7.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -20.18
Net Income -19.77
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -13.07
Cash from Investing 0.00
Cash from Financing 9.27

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 87,401 450,546 19.40
2024-04-25 71,528 166,189 43.04
2024-04-24 114,304 397,706 28.74
2024-04-23 48,821 237,396 20.57

(click for more detail)

Similar Companies
IBIO – iBio, Inc. IGC – IGC Pharma, Inc.
LCTX – Lineage Cell Therapeutics, Inc. MTNB – Matinas BioPharma Holdings, Inc.
NBY – NovaBay Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io